FDA-Approved HIV MedicationsConference Coverage

More Research Points to Weight Increases on TAF-Containing HIV Treatment

medical scale
patrickheagney via iStock
    • “Weight Change in Suppressed People with HIV (PWH) Switched from Either Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) to Tenofovir Alafenamide (TAF).” IDWeek 2020. Abstract LB-7.

    • “Impact of Switching to an Antiretroviral Regimen Containing Tenofovir Alafenamide on Weight Gain and Development of Metabolic Side Effects.” IDWeek 2020. Abstract 107.

    • “Weight change associated with switching to bictegravir/emtricitabine/tenofovir alafenamide in virally suppressed people with HIV.” IDWeek 2020. Abstract 1047.

    Michael Broder

    Michael Broder

    Michael H. Broder is a same-sex-married, HIV-positive man of learning and letters living in Bed-Stuy, Brooklyn.